The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO GI 2024 | Benefits of using stereotactic body radiation therapy for colon cancer
Laura Dawson, MD, University of Toronto, Toronto, Canada, discusses randomized studies on using stereotactic body radiation therapy (SBRT) for patients with colon cancer and multiple lesions. Advances in SBRT delivery are highlighted, including improved precision and dose adjustment, as well as the opportunity to use sensitizers. Additionally, cone beam computed tomography (CBCT)-based imaging can help to enhance treatment effectiveness. This interview took place at 2024 European Society for Medical Oncology (ESMO) Gastrointestinal Cancer Annual Congress in Munich, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
